About FDA
Number of highest risk domestic inspections in the month resulting in a classification of No Action Indicated (NAI)
Dictionary: The number of high-risk product inspections where no objectionable conditions or practices were found during the inspection (or the significance of the documented objectionable conditions found does not justify further FDA action) are classified as No Action Indicated.
Fiscal Year - 2012
| Time | Target | Number Classified as NAI |
|---|---|---|
| Oct 2011 | N/A | 691 |
| Nov 2011 | N/A | 766 |
| Dec 2011 | N/A | 819 |
| Jan 2012 | N/A | 697 |
| Feb 2012 | N/A | 725 |
| Mar 2012 | N/A | 890 |
| Apr 2012 | N/A | 596 |
| May 2012 | N/A | 615 |
| Jun 2012 | N/A | 622 |
| Jul 2012 | N/A | 478 |
| Aug 2012 | N/A | 607 |
| Sep 2012 | N/A | 463 |
FY 2012 Total: 7,969
Percent of highest risk domestic inspections in the month resulting in a classification of No Action Indicated
Fiscal Year - 2012
| Time | Target | Percent Classified as NAI |
|---|---|---|
| Oct 2011 | N/A | 65 |
| Nov 2011 | N/A | 61 |
| Dec 2011 | N/A | 62 |
| Jan 2012 | N/A | 58 |
| Feb 2012 | N/A | 59 |
| Mar 2012 | N/A | 59 |
| Apr 2012 | N/A | 56 |
| May 2012 | N/A | 52 |
| Jun 2012 | N/A | 52 |
| Jul 2012 | N/A | 52 |
| Aug 2012 | N/A | 57 |
| Sep 2012 | N/A | 56 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
